SLC5A10
gene geneOn this page
Also known as SGLT5
Summary
SLC5A10 (solute carrier family 5 member 10, HGNC:23155) is a protein-coding gene on chromosome 17p11.2, encoding Sodium/mannose cotransporter SLC5A10 (A0PJK1). Electrogenic Na+-coupled sugar symporter that actively transports D-mannose or D-fructose at the plasma membrane, with a Na+ to sugar coupling ratio of 1:1.
This gene is a member of the sodium/glucose transporter family. Members of this family are sodium-dependent transporters and can be divided into two subfamilies based on sequence homology, one that co-transports sugars and the second that transports molecules such as ascorbate, choline, iodide, lipoate, monocaroboxylates, and pantothenate. The protein encoded by this gene has the highest affinity for mannose and has been reported to be most highly expressed in the kidney. This protein may function as a kidney-specific, sodium-dependent mannose and fructose co-transporter. Alternative splicing results in multiple transcript variants that encode different protein isoforms.
Source: NCBI Gene 125206 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 89 total
- MANE Select transcript:
NM_001042450
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23155 |
| Approved symbol | SLC5A10 |
| Name | solute carrier family 5 member 10 |
| Location | 17p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SGLT5 |
| Ensembl gene | ENSG00000154025 |
| Ensembl biotype | protein_coding |
| OMIM | 618636 |
| Entrez | 125206 |
Gene structure
Transcript identifiers
Ensembl transcripts: 8 — 7 protein_coding, 1 retained_intron
ENST00000317977, ENST00000395643, ENST00000395645, ENST00000395647, ENST00000417251, ENST00000584658, ENST00000884499, ENST00000961493
RefSeq mRNA: 5 — MANE Select: NM_001042450
NM_001042450, NM_001270648, NM_001270649, NM_001282417, NM_152351
CCDS: CCDS11201, CCDS42275, CCDS59277, CCDS59278, CCDS74008
Canonical transcript exons
ENST00000395645 — 15 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001156144 | 19020155 | 19020212 |
| ENSE00001156149 | 19019713 | 19019928 |
| ENSE00001156156 | 19019423 | 19019591 |
| ENSE00001156183 | 18971013 | 18971218 |
| ENSE00001156187 | 18969342 | 18969422 |
| ENSE00001186829 | 18976854 | 18976989 |
| ENSE00001238189 | 18969052 | 18969157 |
| ENSE00001303766 | 18959135 | 18959239 |
| ENSE00001321494 | 18959604 | 18959663 |
| ENSE00001522377 | 19013410 | 19013517 |
| ENSE00001661487 | 18960548 | 18960652 |
| ENSE00001715901 | 19015049 | 19015199 |
| ENSE00003473902 | 18952165 | 18952316 |
| ENSE00003615558 | 18958682 | 18958753 |
| ENSE00003903495 | 19020325 | 19022565 |
Expression profiles
Bgee: expression breadth ubiquitous, 105 present calls, max score 96.47.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2759 / max 119.7524, expressed in 33 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 159825 | 0.1398 | 26 |
| 159827 | 0.1328 | 6 |
| 159826 | 0.0033 | 3 |
Top tissues by expression
226 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| kidney epithelium | UBERON:0004819 | 96.47 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 87.78 | gold quality |
| kidney | UBERON:0002113 | 82.21 | gold quality |
| adult organism | UBERON:0007023 | 81.74 | gold quality |
| cortex of kidney | UBERON:0001225 | 76.81 | gold quality |
| metanephros cortex | UBERON:0010533 | 75.47 | gold quality |
| upper arm skin | UBERON:0004263 | 74.90 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 72.07 | gold quality |
| ileal mucosa | UBERON:0000331 | 70.72 | silver quality |
| renal medulla | UBERON:0000362 | 70.06 | gold quality |
| tibialis anterior | UBERON:0001385 | 68.91 | silver quality |
| metanephros | UBERON:0000081 | 68.68 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 68.58 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 68.31 | gold quality |
| spleen | UBERON:0002106 | 66.86 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 66.78 | gold quality |
| gingival epithelium | UBERON:0001949 | 66.63 | silver quality |
| myocardium | UBERON:0002349 | 65.65 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 65.53 | gold quality |
| bone marrow | UBERON:0002371 | 65.22 | gold quality |
| bone marrow cell | CL:0002092 | 64.41 | silver quality |
| deltoid | UBERON:0001476 | 64.12 | gold quality |
| gingiva | UBERON:0001828 | 63.81 | silver quality |
| oocyte | CL:0000023 | 63.40 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 63.09 | gold quality |
| blood | UBERON:0000178 | 62.96 | gold quality |
| vena cava | UBERON:0004087 | 62.70 | gold quality |
| pancreatic ductal cell | CL:0002079 | 62.23 | silver quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 61.55 | gold quality |
| granulocyte | CL:0000094 | 61.51 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.71 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
17 targeting SLC5A10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-4713-5P | 99.78 | 67.80 | 1794 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-3679-3P | 99.64 | 69.88 | 1599 |
| HSA-MIR-4743-3P | 99.62 | 68.12 | 2095 |
| HSA-MIR-203A-3P | 99.49 | 70.56 | 2806 |
| HSA-MIR-4735-5P | 99.43 | 68.49 | 1780 |
| HSA-MIR-1227-5P | 98.65 | 65.32 | 1549 |
| HSA-MIR-3944-5P | 98.50 | 67.55 | 997 |
| HSA-MIR-6747-3P | 97.73 | 64.84 | 1596 |
| HSA-MIR-1913 | 97.07 | 66.20 | 1417 |
| HSA-MIR-4749-3P | 96.40 | 66.24 | 798 |
| HSA-MIR-6834-5P | 96.25 | 64.88 | 823 |
| HSA-MIR-635 | 96.00 | 65.54 | 687 |
| HSA-MIR-6774-5P | 95.94 | 65.18 | 722 |
Literature-anchored findings (GeneRIF, showing 5)
- SGLT-5 as a kidney mannose transporter (PMID:22212718)
- hSGLT5 is a sodium/mannose transporter that is blocked by phlorizin. Li(+) and H(+) ions were also able to drive mannose transport, and transport was electrogenic. (PMID:24573086)
- Results show that rs2257609 C>T is located in the intron region of SLC5A10 and is significantly associated with worse overall and disease-free survival of non-small-cell lung cancer (NSCLC) patients. The rs2257609 C>T variant does not affect the expression of SLC5A10 mRNA, but alters the mRNA expression and promoter activity of DRG2. (PMID:30281872)
- Rare variants in SLC5A10 are associated with serum 1,5-anhydroglucitol (1,5-AG) in the Atherosclerosis Risk in Communities (ARIC) Study. (PMID:30976018)
- SGLT5 is the renal transporter for 1,5-anhydroglucitol, a major player in two rare forms of neutropenia. (PMID:37594549)
Cross-species orthologs
15 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | slc5a10 | ENSDARG00000074212 |
| mus_musculus | Slc5a10 | ENSMUSG00000042371 |
| rattus_norvegicus | Slc5a10 | ENSRNOG00000002616 |
| drosophila_melanogaster | CG2187 | FBGN0017448 |
| drosophila_melanogaster | rumpel | FBGN0029950 |
| drosophila_melanogaster | SLC5A11 | FBGN0031998 |
| drosophila_melanogaster | bumpel | FBGN0037895 |
| drosophila_melanogaster | ChT | FBGN0038641 |
| drosophila_melanogaster | salt | FBGN0039872 |
| drosophila_melanogaster | Smvt | FBGN0039873 |
| drosophila_melanogaster | CG31262 | FBGN0051262 |
| drosophila_melanogaster | CG31668 | FBGN0051668 |
| drosophila_melanogaster | CG33124 | FBGN0053124 |
| drosophila_melanogaster | kumpel | FBGN0250757 |
| caenorhabditis_elegans | WBGENE00000501 |
Paralogs (12): SLC5A1 (ENSG00000100170), SLC5A4 (ENSG00000100191), SLC5A5 (ENSG00000105641), SLC5A7 (ENSG00000115665), SLC5A9 (ENSG00000117834), SLC5A6 (ENSG00000138074), SLC5A2 (ENSG00000140675), SLC5A12 (ENSG00000148942), SLC5A11 (ENSG00000158865), SLC5A3 (ENSG00000198743), SLC5A8 (ENSG00000256870), (ENSG00000293606)
Protein
Protein identifiers
Sodium/mannose cotransporter SLC5A10 — A0PJK1 (reviewed: A0PJK1)
Alternative names: Sodium/glucose cotransporter 5, Solute carrier family 5 member 10
All UniProt accessions (1): A0PJK1
UniProt curated annotations — full annotation on UniProt →
Function. Electrogenic Na+-coupled sugar symporter that actively transports D-mannose or D-fructose at the plasma membrane, with a Na+ to sugar coupling ratio of 1:1. Transporter activity is driven by a transmembrane Na+ electrochemical gradient set by the Na+/K+ pump. Exclusively recognizes sugar substrates having a pyranose ring with an axial hydroxyl group on carbon 2. Has likely evolved to enable renal reabsorption of D-mannose, an important constituent of oligosaccharide chains of glycoproteins. Contributes to dietary D-fructose reabsorption from glomerular filtrate across the brush border of the kidney. Appears to have no transporter activity.
Subcellular location. Apical cell membrane.
Tissue specificity. Predominantly expressed at high levels in kidney. Very low expression is detected in testes. Expressed in kidney. The most abundant isoform expressed in kidney. Expressed in kidney. Expressed in kidney.
Activity regulation. Inhibited by phlorizin.
Similarity. Belongs to the sodium:solute symporter (SSF) (TC 2.A.21) family.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| A0PJK1-1 | 1, IF2 | yes |
| A0PJK1-2 | 2, IF3 | |
| A0PJK1-3 | 3 | |
| A0PJK1-4 | 4, IF1 | |
| A0PJK1-5 | 5, IF4 |
RefSeq proteins (5): NP_001035915, NP_001257577, NP_001257578, NP_001269346, NP_689564 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001734 | Na/solute_symporter | Family |
| IPR018212 | Na/solute_symporter_CS | Conserved_site |
| IPR038377 | Na/Glc_symporter_sf | Homologous_superfamily |
Pfam: PF00474
Catalyzed reactions (Rhea), 2 shown:
- D-mannose(out) + Na(+)(out) = D-mannose(in) + Na(+)(in) (RHEA:72907)
- D-fructopyranose(out) + Na(+)(out) = D-fructopyranose(in) + Na(+)(in) (RHEA:72915)
UniProt features (40 total): topological domain 14, transmembrane region 14, splice variant 5, modified residue 3, glycosylation site 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0PJK1-F1 | 88.17 | 0.57 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (3): 141, 145, 148
Glycosylation sites (2): 4, 96
Function
Pathways and Gene Ontology
Reactome pathways
3 pathways
| ID | Pathway |
|---|---|
| R-HSA-189200 | Cellular hexose transport |
| R-HSA-382551 | Transport of small molecules |
| R-HSA-425407 | SLC-mediated transmembrane transport |
MSigDB gene sets: 55 (showing top):
GOBP_CARBOHYDRATE_TRANSPORT, GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT, CAGCTG_AP4_Q5, GOBP_MONOATOMIC_CATION_TRANSPORT, HEN1_01, GOCC_APICAL_PLASMA_MEMBRANE, GOBP_TRANSMEMBRANE_TRANSPORT, GOBP_SODIUM_ION_TRANSPORT, GOCC_APICAL_PART_OF_CELL, GOCC_PLASMA_MEMBRANE_REGION, GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY, GOMF_SOLUTE_MONOATOMIC_CATION_SYMPORTER_ACTIVITY
GO Biological Process (7): hexose transmembrane transport (GO:0008645), monoatomic ion transport (GO:0006811), sodium ion transport (GO:0006814), fructose transmembrane transport (GO:0015755), mannose transmembrane transport (GO:0015761), sodium ion transmembrane transport (GO:0035725), transmembrane transport (GO:0055085)
GO Molecular Function (5): D-glucose:sodium symporter activity (GO:0005412), solute:sodium symporter activity (GO:0015370), mannose:sodium symporter activity (GO:0140929), fructose:sodium symporter activity (GO:0140930), transmembrane transporter activity (GO:0022857)
GO Cellular Component (4): plasma membrane (GO:0005886), apical plasma membrane (GO:0016324), extracellular exosome (GO:0070062), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| SLC-mediated transmembrane transport | 1 |
| Transport of small molecules | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| carbohydrate:monoatomic cation symporter activity | 3 |
| solute:sodium symporter activity | 3 |
| transport | 2 |
| hexose transmembrane transport | 2 |
| monosaccharide transmembrane transport | 1 |
| metal ion transport | 1 |
| sodium ion transport | 1 |
| monoatomic cation transmembrane transport | 1 |
| cellular process | 1 |
| D-glucose transmembrane transporter activity | 1 |
| sodium ion transmembrane transporter activity | 1 |
| solute:monoatomic cation symporter activity | 1 |
| mannose transmembrane transporter activity | 1 |
| fructose transmembrane transporter activity | 1 |
| transporter activity | 1 |
| transmembrane transport | 1 |
| membrane | 1 |
| cell periphery | 1 |
| apical part of cell | 1 |
| plasma membrane region | 1 |
| extracellular vesicle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
803 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SLC5A10 | SLC2A2 | P11168 | 635 |
| SLC5A10 | SLC2A5 | P22732 | 552 |
| SLC5A10 | GOLT1A | Q6ZVE7 | 454 |
| SLC5A10 | SLC60A2 | Q5TF39 | 425 |
| SLC5A10 | SLC1A1 | P43005 | 423 |
| SLC5A10 | SACK1G | A6ND36 | 418 |
| SLC5A10 | PPTC7 | Q8NI37 | 408 |
| SLC5A10 | CFAP20DC | Q6ZVT6 | 406 |
| SLC5A10 | CCAR1 | Q8IX12 | 403 |
| SLC5A10 | SLC15A1 | P46059 | 390 |
| SLC5A10 | CNOT12 | Q9C0C2 | 383 |
| SLC5A10 | SEC24A | O95486 | 382 |
| SLC5A10 | SLC50A1 | Q9BRV3 | 373 |
| SLC5A10 | RD3L | P0DJH9 | 364 |
| SLC5A10 | MPRIP | Q6WCQ1 | 363 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SLC5A10 | UBQLN4 | psi-mi:“MI:0914”(association) | 0.350 |
| SLC5A1 | SLC5A10 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (4): UBQLN4 (Affinity Capture-MS), UBQLN1 (Affinity Capture-MS), SLC5A10 (Proximity Label-MS), SLC5A10 (Affinity Capture-MS)
ESM2 similar proteins: A0PJK1, A8I1B9, A8WHP3, B9NAE4, D3ZIS0, O02228, O77741, P11170, P13866, P26429, P26430, P31636, P31637, P31639, P41251, P49279, P49280, P53790, P53791, P53792, P53793, P53794, P56436, P70553, P83740, Q27946, Q27981, Q28610, Q28728, Q2M3M2, Q3ZC26, Q5FY69, Q5SWY8, Q6R4Q5, Q7T384, Q8BGY9, Q8C3K6, Q8K0E3, Q8UWF0, Q8VDT1
Diamond homologs: A0PJK1, A8I1B9, A8WHP3, D3ZIS0, P11170, P13866, P26429, P26430, P31636, P31637, P31639, P53790, P53791, P53792, P53793, P53794, P96169, Q28610, Q28728, Q2M3M2, Q3ZC26, Q5FY69, Q5SWY8, Q6R4Q5, Q8C3K6, Q8K0E3, Q8VDT1, Q8WWX8, Q91ZP4, Q923I7, Q9ET37, Q9JKZ2, Q9NY91, Q9Z1F2, P31448
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
89 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 78 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
4261 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:18958680:A:AG | acceptor_gain | 1.0000 |
| 17:18958681:G:GG | acceptor_gain | 1.0000 |
| 17:18958681:GTCC:G | acceptor_gain | 1.0000 |
| 17:18958681:GTCCT:G | acceptor_gain | 1.0000 |
| 17:18958751:CCGGT:C | donor_loss | 1.0000 |
| 17:18958752:CGGTG:C | donor_loss | 1.0000 |
| 17:18958753:GGT:G | donor_loss | 1.0000 |
| 17:18958754:G:C | donor_loss | 1.0000 |
| 17:18958754:G:GG | donor_gain | 1.0000 |
| 17:18958755:T:A | donor_loss | 1.0000 |
| 17:18959130:TCCA:T | acceptor_loss | 1.0000 |
| 17:18959131:CCA:C | acceptor_loss | 1.0000 |
| 17:18959133:A:AG | acceptor_gain | 1.0000 |
| 17:18959133:AGATT:A | acceptor_gain | 1.0000 |
| 17:18959134:G:GA | acceptor_gain | 1.0000 |
| 17:18959134:GA:G | acceptor_gain | 1.0000 |
| 17:18959134:GAT:G | acceptor_gain | 1.0000 |
| 17:18959134:GATT:G | acceptor_gain | 1.0000 |
| 17:18959134:GATTG:G | acceptor_gain | 1.0000 |
| 17:18959235:GGAAT:G | donor_gain | 1.0000 |
| 17:18959236:GAAT:G | donor_gain | 1.0000 |
| 17:18959236:GAATG:G | donor_gain | 1.0000 |
| 17:18959238:AT:A | donor_gain | 1.0000 |
| 17:18959238:ATGTG:A | donor_loss | 1.0000 |
| 17:18959240:G:GG | donor_gain | 1.0000 |
| 17:18959240:G:T | donor_loss | 1.0000 |
| 17:18959241:T:A | donor_loss | 1.0000 |
| 17:18959602:A:AG | acceptor_gain | 1.0000 |
| 17:18959603:G:GG | acceptor_gain | 1.0000 |
| 17:18959660:AGAGG:A | donor_loss | 1.0000 |
AlphaMissense
3825 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 17:18976920:A:C | S305R | 0.997 |
| 17:18976922:C:A | S305R | 0.997 |
| 17:18976922:C:G | S305R | 0.997 |
| 17:18976971:A:C | S322R | 0.997 |
| 17:18976973:C:A | S322R | 0.997 |
| 17:18976973:C:G | S322R | 0.997 |
| 17:19019451:A:C | S424R | 0.997 |
| 17:19019453:T:A | S424R | 0.997 |
| 17:19019453:T:G | S424R | 0.997 |
| 17:18959156:A:C | S69R | 0.995 |
| 17:18959158:C:A | S69R | 0.995 |
| 17:18959158:C:G | S69R | 0.995 |
| 17:18976975:G:C | R323P | 0.995 |
| 17:19013494:T:C | L356P | 0.995 |
| 17:19015117:A:C | S387R | 0.995 |
| 17:19015119:C:A | S387R | 0.995 |
| 17:19015119:C:G | S387R | 0.995 |
| 17:18959228:T:C | F93L | 0.994 |
| 17:18959230:C:A | F93L | 0.994 |
| 17:18959230:C:G | F93L | 0.994 |
| 17:18971159:T:A | W263R | 0.994 |
| 17:18971159:T:C | W263R | 0.994 |
| 17:18976865:G:C | Q286H | 0.994 |
| 17:18976865:G:T | Q286H | 0.994 |
| 17:19015123:A:C | S389R | 0.994 |
| 17:19015125:C:A | S389R | 0.994 |
| 17:19015125:C:G | S389R | 0.994 |
| 17:18969398:G:A | G206R | 0.993 |
| 17:18969398:G:C | G206R | 0.993 |
| 17:18976879:C:A | A291D | 0.993 |
dbSNP variants (sampled 300 via entrez): RS1000017554 (17:18979405 CG>C), RS1000040617 (17:19013460 G>A), RS1000108166 (17:19005577 G>C), RS1000119288 (17:18982264 C>G), RS1000156355 (17:18968490 G>A), RS1000190467 (17:18982965 G>A), RS1000198665 (17:18967288 C>A,G,T), RS1000230446 (17:19017992 T>C), RS1000235019 (17:19020856 G>C), RS1000254136 (17:18967113 C>T), RS1000305407 (17:19006343 C>G,T), RS1000423531 (17:18968662 C>G), RS1000459233 (17:18972523 G>A), RS1000612309 (17:19015852 T>C), RS1000636305 (17:19006672 A>C)
Disease associations
OMIM: gene MIM:618636 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004643_2 | 1,5-anhydroglucitol levels | 2.000000e-17 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008009 | 1,5 anhydroglucitol measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: transporter — Hexose transporter family
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases expression | 2 |
| Resveratrol | affects cotreatment, decreases expression | 2 |
| propionaldehyde | increases expression | 1 |
| mono-(2-ethylhexyl)phthalate | decreases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | increases expression | 1 |
| bisphenol S | affects cotreatment, increases methylation | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| Fulvestrant | increases methylation, affects cotreatment | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Endosulfan | increases expression | 1 |
| Methapyrilene | increases methylation | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | increases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Zinc | affects cotreatment, increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.